European Archives - Page 461 of 1590 - European Medical Journal

Advances in 2L ER+/HER2− mBC therapy

Despite advances in first-line endocrine therapy (ET) plus cyclin-dependent 4/6 kinase inhibitors (CDK4/6i) in oestrogen receptor-positive…

EMJ Oncology 13 [Supplement 2] 2025

A review of the latest strategies for managing oestrogen therapy resistance in ER+/HER2− metastatic breast cancer, focusing on biomarker…

ESPID 2025: Cell-Based Influenza Vaccine Offers Better Protection in Children

New data from a large paediatric cohort suggest that cell-based influenza vaccines provide improved protection over egg-based formulations.

Flu Vaccine Prevented Over 100,000 Hospitalisations Last Winter

Flu vaccination prevented up to 120,000 hospital admissions in England during the 2024/25 season, despite concerning declines in uptake among some vulnerable groups.

Autism in Toddlers: No Early Sex Differences at First Diagnosis

Major study finds no early clinical differences between autistic boys and girls at the time of first diagnosis.

ESPID 2025: Spain’s Infant Antibody Programme Outperforms UK Maternal Vaccine

A comparison of national RSV prevention strategies has shown that monoclonal antibody immunisation in Spain was vastly more effective than maternal vaccination in the UK.

Tezepelumab Achieves Clinical Remission in Severe Asthma

Interestingly, the study also revealed a disconnect between clinical and biological remission.

EMJ Allergy & Immunology 10 [Supplement 2] 2025

Hereditary angioedema (HAE) attacks can be debilitating and potentially life-threatening, particularly when they affect the abdomen or…

Berotralstat for HAE Prophylaxis

Hereditary angioedema (HAE) attacks can be debilitating and potentially life-threatening, particularly when they affect the…

Two illustrated hands, one holding money, the other a first aid box

King’s Fund sheds light on access to medicine in UK

The King’s Fund in the UK has released an updated explainer on the availability of new medicines in the UK’s NHS.